OMEGA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.27 USD | -3.40% |
|
-5.42% | -24.58% |
| 16/04 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
| 16/04 | Omega Therapeutics, Inc. Announces Executive Changes, Effective as of May 31, 2024 | CI |
Chart calendar Omega Therapeutics, Inc.
70a45847ab1a25aa007.Uii2ufjSv5k6GeExnKSvD48AlPihQoMNJSY8P7-Mvfg.NHeO7LWWycYDVKhp-ODiSrlzps7IMc15bnlsapLF9rQ9W_KAv5_d33tcsA~c5a5a1fc9ae23bd9b36f45395a56d637
Upcoming events on Omega Therapeutics, Inc.
Past events on Omega Therapeutics, Inc.
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract Number: 2417 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract Number: 1726 |
| 28/03/2024 06:45 pm | Q4 2023 Earnings Release |
| 11/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 06/12/2023 08:00 pm | H.C. Wainwright Precision Oncology Virtual Conference |
| 29/11/2023 10:30 pm | Piper Sandler Healthcare Conference |
| 14/11/2023 06:00 pm | Jefferies London Healthcare Conference |
| 12/11/2023 11:30 pm | AASLD Liver Meeting - Poster number: 3444-A |
| 11/11/2023 11:30 pm | AASLD Liver Meeting - Poster number: 2621-A |
| 09/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 31/10/2023 08:30 pm | International mRNA Health Conference - Poster #: 79 |
| 14/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - Poster number: C104 |
| 03/10/2023 09:00 pm | Chardan Genetic Medicines Conference |
| 27/09/2023 05:30 pm | Jefferies Cell & Genetic Medicine Summit |
| 26/09/2023 05:30 pm | OTX Phase 1/2 Trial Results Call |
| 04/08/2023 01:30 am | Q2 2023 Earnings Release |
| 15/06/2023 03:10 am | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 06:00 pm | Jefferies Healthcare Conference |
| 07/06/2023 06:30 pm | Annual General Meeting |
| 05/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract No - 4116 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,14 0,00 - | 2,07 1,58 30.91% | 3,09 2,53 22.34% | 3,37 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -64,6 -62,7 -3.16% | -101 -95,8 -5.67% | 0,00 -104 - | -94,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -66,0 -67,4 2.04% | -103 -102 -0.73% | -100 -107 5.95% | -82,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -68,3 -71,4 4.34% | -103 -100 -2.21% | -97,4 -103 5.03% | -74,1 |
|
Net income Million USD | Released Forecast Spread | -29,4 | -68,3 -71,6 4.62% | -103 -102 -1.15% | -97,4 -103 5.03% | -74,1 |
|
EPS USD | Released Forecast Spread | -7,56 | -3,05 -2,69 -13.59% | -2,14 -2,12 -0.75% | -1,80 -1,86 3.1% | -1,23 |
| Announcement Date | 09/07/21 | 10/03/22 | 01/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,14 0,00 - | 0,27 0,00 - | 0,48 0,05 824.27% | 0,60 0,10 487.94% | 0,74 0,26 185.44% | 0,52 0,31 66.45% | 0,76 0,43 76.51% | 0,83 0,38 116.78% | 0,99 0,53 86.6% | 1,16 | 1,16 | 0,52 | 0,52 | 0,50 |
|
EBIT Million USD | Released Forecast Spread | -20,7 -22,0 6.21% | -20,0 -26,9 25.72% | -25,9 -24,7 -4.75% | -26,0 -29,6 12.16% | -31,0 -30,2 -2.46% | -25,8 -32,8 21.36% | -30,8 -29,0 -6.47% | -22,9 -31,6 27.49% | -20,7 -27,0 23.43% | -20,6 | -20,4 | -20,6 | -21,3 | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,9 -24,0 12.93% | -20,2 -24,8 18.55% | -25,9 -22,9 -13.33% | -25,8 -28,3 8.79% | -30,8 -28,6 -7.75% | -25,3 -31,1 18.64% | -29,7 -27,9 -6.58% | -22,2 -30,7 27.58% | -20,2 -25,4 20.33% | -19,6 | -18,5 | -18,2 | -17,6 | -14,0 |
|
Net income Million USD | Released Forecast Spread | -20,9 -24,1 13.56% | -20,2 -27,0 25.33% | -25,9 -25,6 -1.05% | -25,8 -30,0 13.88% | -30,8 -29,7 -3.94% | -25,3 -32,6 22.41% | -29,7 -27,9 -6.58% | -22,2 -30,7 27.58% | -20,2 -25,4 20.33% | -19,6 | -18,5 | -18,2 | -17,6 | -14,0 |
|
EPS USD | Released Forecast Spread | -0,44 -0,63 29.6% | -0,42 -0,57 25.88% | -0,54 -0,54 -0.62% | -0,54 -0,62 12.2% | -0,64 -0,62 -2.89% | -0,50 -0,63 20.13% | -0,54 -0,50 -7.57% | -0,40 -0,55 26.74% | -0,37 -0,45 17.32% | -0,36 | -0,33 | -0,29 | -0,26 | -0,25 |
| Announcement Date | 10/03/22 | 04/05/22 | 04/08/22 | 08/11/22 | 01/03/23 | 04/05/23 | 03/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Omega Therapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OMGA Stock
- Calendar Omega Therapeutics, Inc.
